EP
IFRX icon

Eversept Partners’s InflaRx IFRX Stock Holding History

Eversept Partners’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Sell
1,304,069
-454,504
-26% -$854K 0.15% 79
2026
Q1 		$1.57M Buy
1,758,573
+1,261
+0.1% +$1.19K 0.08% 94
2025
Q4 		$1.77M Buy
1,757,312
+26,677
+2% +$33.1K 0.09% 89
2025
Q3 		$2.32M Buy
1,730,635
+90,205
+5% +$95.8K 0.16% 65
2025
Q2 		$1.3M Sell
1,640,430
-35,548
-2% -$42K 0.12% 59
2025
Q1 		$1.71M Buy
1,675,978
+1,183,526
+240% +$2.23M 0.17% 47
2024
Q4 		$1.22M Sell
492,452
-1,129,335
-70% -$2.17M 0.11% 61
2024
Q3 		$2.48M Buy
1,621,787
+54,857
+4% +$83.5K 0.17% 56
2024
Q2 		$2.73M Buy
1,566,930
+261,790
+20% +$384K 0.19% 57
2024
Q1 		$2.01M Hold
1,305,140
– – 0.13% 61
2023
Q4 		$2.13M Sell
1,305,140
-432,404
-25% -$741K 0.19% 50
2023
Q3 		$5.18M Sell
1,737,544
-177,569
-9% -$676K 0.44% 40
2023
Q2 		$8.54M Buy
+1,915,113
New +$8.57M 0.71% 31
2021
Q2 		– Sell
-268,634
Closed -$1.05M – 97
2021
Q1 		$1.05M Buy
+268,634
New +$1.38M 0.05% 77
2020
Q2 		– Sell
-195,488
Closed -$747K – 73
2020
Q1 		$747K Sell
195,488
-139,130
-42% -$515K 0.19% 49
2019
Q4 		$1.33M Buy
+334,618
New +$978K 0.23% 59

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Eversept Partners's IFRX Position: Q2 2026 in Review

Eversept Partners reduced its InflaRx (IFRX) stake by 26% in Q2 2026, selling an estimated $854K and leaving 1,304,069 shares worth $2.92M. The position accounts for 0.15% of the portfolio, ranked #79.

Eversept Partners first reported a position in IFRX in Q4 2019 and has held it in 16 quarters since. The position peaked at $8.54M in Q2 2023. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Eversept Partners held 1,304,069 shares of InflaRx worth $2.92M as of Q2 2026.
  • Eversept Partners sold 454,504 InflaRx shares in Q2 2026, an estimated $854K.
  • InflaRx made up 0.15% of Eversept Partners's portfolio in Q2 2026, its #79 holding.
  • Eversept Partners first reported a position in InflaRx in Q4 2019 and has held it in 16 quarters since.
  • Eversept Partners's InflaRx position peaked at $8.54M in Q2 2023.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.